揭示微量元素在调节CAG重复驱动的脊髓小脑动力衰竭中炎症和氧化途径中的作用
Surbhi Singh1, Deepika Joshi2, Abhay Kumar Yadav1
1Department of Anatomy, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Cytokine
|October 12, 2025
概括
脊髓小脑缩症 (SCAs) 涉及的不仅仅是遗传突变. 系统性因素,如微量元素失衡,氧化应激和炎症显著促进SCA进展和神经退行.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 生物化学 生物化学
背景情况:
- 脊髓小脑缩症 (SCAs) 是一种遗传性神经退行性疾病,通常是由基因突变引起的.
- 新出现的证据表明,SCA进展中存在系统因素,包括微量元素失衡,氧化应激和免疫失调.
研究的目的:
- 研究SCA患者的微量元素水平,氧化应激和炎症之间的相互作用.
- 确定SCA诊断的潜在生物标志物,了解疾病机制.
主要方法:
- 使用原子吸收光谱在SCA患者和对照组中分析血微量元素.
- 通过ELISA对氧化应激标志物和细胞因子 (例如GPx,IL-10) 的量化.
- 分子对接和生物信息学分析,以探索分子相互作用和途径.
主要成果:
- 在SCA患者中发现了基本和有毒微量元素度的显著变化.
- 观察到高氧化应激和改变的细胞因子概况,GPx和IL-10显示出高的诊断准确性.
- 鉴定了微量元素失调,氧化应激和炎症之间的相互联系,这表明在神经退行症中发挥了协同作用.
结论:
- SCA的发病过程很复杂,涉及遗传突变和系统因素.
- 微量元素失衡,氧化应激和炎症形成了一种致病网络,有助于神经退行.
- 将这些系统因素与遗传因素一起定位可能为SCAs提供新的治疗策略.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...


